1. The “new” era of oral antineoplastic drug therapy: Revisiting “old” concerns

   • Maurie Markman

   Editor’s Commentary Pages: 317 - 318

2. Web alert

   News Pages: 319 - 319

3. Minimal residual disease quantification in adult acute lymphoblastic leukemia

   • Heather Landau
   • Mark A. Weiss

   Clinical Trials Report Pages: 323 - 324

4. Novel approaches in allogeneic stem cell transplantation

   • Esperanza B. Papadopoulos
   • Ann A. Jakubowski

   OriginalPaper Pages: 325 - 336

5. Hairy cell leukemia

   • Claire Dearden
   • Monica Else

   OriginalPaper Pages: 337 - 342

6. Philadelphia chromosome-positive acute lymphoblastic leukemia: Impact of imatinib treatment on remission induction and allogeneic stem cell transplantation

   • Tibor Kovacsovics
   • Richard T. Maziarz

   OriginalPaper Pages: 343 - 351

7. Comparison of ABVD chemotherapy and a regimen including radiotherapy in patients with limited-stage Non-Hodgkin’s lymphoma

   • Carol S. Portlock

   Clinical Trials Report Pages: 355 - 356

8. FDG-PET after two cycles of chemotherapy predicts treatment failure and Progression-free survival in Hodgkin’s lymphoma

   • Carol S. Portlock

   Clinical Trials Report Pages: 356 - 357

9. Clinical and molecular prognostic factors in follicular lymphoma

   • Andrew J. Davies

   OriginalPaper Pages: 358 - 367

10. Investigational strategies in autologous stem cell transplantation for follicular lymphoma

    • Oliver Weigert
    • Martin Dreyling
    • Christian Buske

    OriginalPaper Pages: 368 - 375

11. Mycosis fungoides and sezary syndrome: An update

    • Ellen J. Kim
    • Julie Lin
    • Alain H. Rook

    OriginalPaper Pages: 376 - 386

12. Non-Hodgkin’s lymphoma in children and adolescents

    • Neerav N. Shukla
    • Tanya M. Trippett

    OriginalPaper Pages: 387 - 394

13. Sun exposure and mortality from melanoma

    • Kim Margolin

    Clinical Trials Report Pages: 397 - 397

14. Distinct sets of genetic alterations in melanoma

    • Kim Margolin

    Clinical Trials Report Pages: 398 - 399

15. Therapeutic targets in melanoma: MAPKinase pathway

    • Frank G. Haluska
    • Nageatte Ibrahim

    OriginalPaper Pages: 400 - 405